Bovie Medical (BVX) Misses Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Bovie Medical Corporation Reports First Quarter 2016 Results
May 11, 2016 7:00 AM EDTFirst Quarter Highlights
Total revenue increased 26.9% Gross margin was 42.7% J-Plasma® revenues increased 25.8% year-on-year; Positive trends in operating metrics continued in Q1 Company on track for 20% revenue growth for full year 2016CLEARWATER, Fla.--(BUSINESS WIRE)-- Bovie Medical Corporation (NYSEMKT: BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced results for the first quarter ended March 31, 2016.
Management... More



